PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals

Acta Neurologica Scandinavica

Volumn 116, Issue 1, 2007, Pages 26-30

  Schiavon, R ^a   Turazzini, M ^a   De Fanti, E ^a   Battaglia, P ^a   Targa, L ^a   Del Colle, R ^a   Fasolin, A ^a   Silvestri, M ^a   Biasioli, S ^a   Guidi, G ^b  

^a 'Mater Salutis' Hospital   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Acute cerebral infarction; Genetics of stroke; Oxidant stress; Paraoxonase; Risk factors for stroke

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; STROKE; SURVIVOR;

ADULT; AGED; AGED, 80 AND OVER; ARYLDIALKYLPHOSPHATASE; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34250825537     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00765.x     Document Type: Article

References (22)

1. Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991 286 : 152 4.
2. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993 3 : 73 6.
3. Garin MC, James RW, Dussoix P et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 1997 99 : 62 6.
4. Ferre N, Camps J, Fernandez-Ballart J et al. Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem 2003 49 : 1491 7.
5. Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res 2003 44 : 780 92.
6. Mackness B, Durrington PN, Abuashia B, Boulton AJ, Mackness MI. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci 2000 98 : 355 63.
7. Mackness MI, Harty D, Bhatnagar D et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 1991 86 : 193 9.
8. Senti M, Tomas M, Vila J et al. Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study. Atherosclerosis 2001 156 : 443 9.
9. Schiavon R, Battaglia P, De Fanti E et al. HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism. Clin Chim Acta 2002 324 : 39 44.
10. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 2004 363 : 689 95.
11. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001 21 : 473 80.
12. Mackness B, Durrington P, McElduff P et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003 107 : 2775 9.
13. Schmidt H, Schmidt R, Niederkorn K et al. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 1998 29 : 2043 8.
14. Leus FR, Wittekoek ME, Prins J, Kastelein JJ, Voorbij HA. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. Atherosclerosis 2000 149 : 371 7.
15. Koch M, Hering S, Barth C, Ehren M, Enderle MD, Pfohl M. Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes. Exp Clin Endocrinol Diabetes 2001 109 : 141 5.
16. Imai Y, Morita H, Kurihara H et al. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 2000 149 : 435 42.
17. Topic E, Timundic AM, Ttefanovic M et al. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med 2001 39 : 346 50.
18. Voetsch B, Benke KS, Damasceno BP, Siqueira LH, Loscalzo J. Paraoxonase 192 Gln->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 2002 33 : 1459 64.
19. Voetsch B, Benke KS, Panhuyssen CI, Damasceno BP, Loscalzo J. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Arch Neurol 2004 61 : 351 6.
20. Ombres D, Pannitteri G, Montali A et al. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients. Arterioscler Thromb Vasc Biol 1998 18 : 1611 6.
21. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 2001 68 : 1428 36.
22. Van Lenten BJ, Hama SY, de Beer FC et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995 96 : 2758 67.